Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-01 Sale |
2021-06-03 5:15 pm |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
23,555 | $16.68 | $392,813 | 47,626 (Direct) |
View |
| 2021-04-30 Sale |
2021-05-04 5:33 pm |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
23,555 | $15.97 | $376,123 | 35,620 (Direct) |
View |
| 2021-04-26 Sale |
2021-04-28 7:32 pm |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
18,255 | $15.22 | $277,783 | 59,175 (Direct) |
View |
| 2021-04-06 Sale |
2021-04-08 4:57 pm |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
5,300 | $15.01 | $79,553 | 77,430 (Direct) |
View |
| 2021-02-17 Purchase |
2021-02-18 6:44 pm |
Oncorus Inc. | ONCR | Flynn James E Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Healthcare Innovations Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner |
300,000 | $19 | $5,700,000 | 345,167 (Indirect) |
View |
| 2020-10-06 Purchase |
2020-10-08 6:35 pm |
Oncorus Inc. | ONCR | MPM SunStates Fund L.P. MPM Asset Management Investors SunStates Fund LLC MPM SunStates Fund GP LLC MPM SunStates GP Managing Member LLC 10% Owner |
173,776 | $15 | $2,606,640 | 2,849,453 (Indirect) |
View |
| 2020-10-06 Purchase |
2020-10-08 6:31 pm |
Oncorus Inc. | ONCR | MPM BioVentures 2014 L.P. Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM ASSET MANAGEMENT LLC 10% Owner |
173,776 | $15 | $2,606,640 | 2,849,453 (Indirect) |
View |
| 2020-10-06 Purchase |
2020-10-08 6:28 pm |
Oncorus Inc. | ONCR | GADICKE ANSBERT 10% Owner |
325,000 | $15 | $4,875,000 | 2,377,025 (Indirect) |
View |
| 2020-10-06 Purchase |
2020-10-08 6:27 pm |
Oncorus Inc. | ONCR | EVNIN LUKE Director 10% Owner |
151,225 | $15 | $2,268,375 | 2,492,843 (Indirect) |
View |
| 2020-10-06 Purchase |
2020-10-08 6:26 pm |
Oncorus Inc. | ONCR | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
151,224 | $15 | $2,268,360 | 2,377,025 (Direct) |
View |
| 2020-10-06 Purchase |
2020-10-08 5:31 pm |
Oncorus Inc. | ONCR | Flynn James E Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Healthcare Innovations Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner |
1,000,000 | $15 | $15,000,000 | 312,282 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-11 Option Award(A) |
2021-06-17 5:45 pm |
N/A 2030-12-10 |
Oncorus Inc. | ONCR | Canute Scott A Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 4:31 pm |
N/A N/A |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
35,561 | $1.81 | 88,962 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 4:31 pm |
N/A 2028-11-13 |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
35,561 | $0 | 88,962 (Direct) |
View |
| 2020-12-31 Exercise |
2021-04-09 4:30 pm |
N/A N/A |
Oncorus Inc. | ONCR | Ashburn Theodore President and CEO |
1,900 | $1.81 | 691,666 (Direct) |
View |
| 2020-12-31 Exercise |
2021-04-09 4:30 pm |
N/A 2028-11-13 |
Oncorus Inc. | ONCR | Ashburn Theodore President and CEO |
6,599 | $0 | 691,666 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 4:30 pm |
N/A N/A |
Oncorus Inc. | ONCR | Ashburn Theodore President and CEO |
4,699 | $5.32 | 691,666 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:14 pm |
N/A 2031-02-28 |
Oncorus Inc. | ONCR | McCabe John P. CFO, Treasurer and Secretary |
76,894 | $0 | 76,894 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:13 pm |
N/A 2031-02-28 |
Oncorus Inc. | ONCR | Goldberg John Mayer SVP, Clinical Development |
61,063 | $0 | 61,063 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:12 pm |
N/A 2031-02-28 |
Oncorus Inc. | ONCR | Ashburn Theodore President and CEO |
199,000 | $0 | 199,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:11 pm |
N/A 2031-02-28 |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
70,109 | $0 | 70,109 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-16 5:15 pm |
N/A 2030-12-10 |
Oncorus Inc. | ONCR | Canute Scott A Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-12-07 Option Award |
2020-12-09 6:59 pm |
N/A 2030-12-06 |
Oncorus Inc. | ONCR | Harbin Stephen COO and Chief of Staff |
169,000 | $0 | 169,000 (Direct) |
View |
Ownership |
2020-12-09 6:57 pm |
N/A 2029-08-14 |
Oncorus Inc. | ONCR | Harbin Stephen COO and Chief of Staff |
0 | $0 | 4,136 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:35 pm |
N/A N/A |
Oncorus Inc. | ONCR | MPM SunStates Fund L.P. MPM Asset Management Investors SunStates Fund LLC MPM SunStates Fund GP LLC MPM SunStates GP Managing Member LLC 10% Owner |
2,559,854 | $0 | 2,849,453 (Indirect) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:33 pm |
N/A N/A |
Oncorus Inc. | ONCR | Nam Spencer Director |
1,924 | $0 | 1,924 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:31 pm |
N/A N/A |
Oncorus Inc. | ONCR | MPM BioVentures 2014 L.P. Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM ASSET MANAGEMENT LLC 10% Owner |
2,559,854 | $0 | 2,849,453 (Indirect) |
View |
| 2020-10-06 Option Award |
2020-10-08 6:30 pm |
N/A 2028-11-13 |
Oncorus Inc. | ONCR | Finer Mitchell H. Director |
42,970 | $0 | 42,970 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:28 pm |
N/A N/A |
Oncorus Inc. | ONCR | GADICKE ANSBERT 10% Owner |
4,785,655 | $0 | 2,377,025 (Indirect) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:27 pm |
N/A N/A |
Oncorus Inc. | ONCR | EVNIN LUKE Director 10% Owner |
2,225,795 | $0 | 2,492,843 (Indirect) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:26 pm |
N/A N/A |
Oncorus Inc. | ONCR | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
2,225,801 | $0 | 2,377,025 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-08 5:31 pm |
N/A N/A |
Oncorus Inc. | ONCR | Flynn James E Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Healthcare Innovations Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner |
23,172,431 | $0 | 312,282 (Indirect) |
View |
| 2020-10-01 Option Award |
2020-10-05 7:12 pm |
N/A 2030-09-14 |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
89,725 | $0 | 89,725 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 7:11 pm |
N/A 2030-09-14 |
Oncorus Inc. | ONCR | Ashburn Theodore President and CEO |
126,624 | $0 | 126,624 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 7:10 pm |
N/A 2030-09-14 |
Oncorus Inc. | ONCR | Goldberg John Mayer SVP, Clinical Development |
56,285 | $0 | 56,285 (Direct) |
View |
Ownership |
2020-10-01 8:07 pm |
N/A N/A |
Oncorus Inc. | ONCR | Finer Mitchell H. Director |
0 | $0 | 346,696 (Direct) |
View |
Ownership |
2020-10-01 7:23 pm |
N/A N/A |
Oncorus Inc. | ONCR | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
0 | $0 | 2,252,947 (Direct) |
View |
Ownership |
2020-10-01 7:19 pm |
N/A N/A |
Oncorus Inc. | ONCR | Queva Christophe CSO and SVP, Research |
0 | $0 | 259,373 (Direct) |
View |
Ownership |
2020-10-01 7:17 pm |
N/A N/A |
Oncorus Inc. | ONCR | Nam Spencer Director |
0 | $0 | 11,851 (Direct) |
View |
Ownership |
2020-10-01 7:16 pm |
N/A N/A |
Oncorus Inc. | ONCR | MPM SunStates Fund L.P. MPM Asset Management Investors SunStates Fund LLC MPM SunStates Fund GP LLC MPM SunStates GP Managing Member LLC 10% Owner |
0 | $0 | 2,718,332 (Indirect) |
View |
Ownership |
2020-10-01 7:15 pm |
N/A N/A |
Oncorus Inc. | ONCR | MPM BioVentures 2014 L.P. Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM ASSET MANAGEMENT LLC 10% Owner |
0 | $0 | 2,718,332 (Indirect) |
View |
Ownership |
2020-10-01 7:13 pm |
N/A 2026-04-26 |
Oncorus Inc. | ONCR | Morrison Briggs Director |
0 | $0 | 32,846 (Direct) |
View |
Ownership |
2020-10-01 7:11 pm |
N/A 2029-02-27 |
Oncorus Inc. | ONCR | McCabe John P. CFO, Treasurer and Secretary |
0 | $0 | 238,723 (Direct) |
View |
Ownership |
2020-10-01 7:09 pm |
N/A 2029-09-06 |
Oncorus Inc. | ONCR | KIRKMAN ROBERT L Director |
0 | $0 | 9,927 (Direct) |
View |
Ownership |
2020-10-01 7:06 pm |
N/A N/A |
Oncorus Inc. | ONCR | Goldberg John Mayer SVP, Clinical Development |
0 | $0 | 172,722 (Direct) |
View |
Ownership |
2020-10-01 7:05 pm |
N/A N/A |
Oncorus Inc. | ONCR | GADICKE ANSBERT 10% Owner |
0 | $0 | 4,971,279 (Indirect) |
View |
Ownership |
2020-10-01 7:04 pm |
N/A 2029-12-18 |
Oncorus Inc. | ONCR | Fenton Mary Kay Director |
0 | $0 | 9,927 (Direct) |
View |